Vertex Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.9% | +55.8% | -23.9% | +6.3% | +12.7% | -1.7% | +17.4% | +4.3% | +10.9% | -1.3% | +9.7% | +0.9% | +48.8% | +7.2% | +0.6% | +0.9% | +5.8% | +5.9% | +4.0% | +10.6% | +4.5% | +1.2% | +4.7% | +6.3% | -1.4% | +3.1% | +5.0% | -0.4% | +1.4% | +6.7% | -1.5% | +4.8% | +5.1% | -4.9% | +7.0% | +3.8% | +4.9% | -7.4% | +11.6% | – | |
| – | +11.8% | -22.3% | +51.5% | +2.3% | +15.3% | -14.8% | +45.8% | +6.6% | +9.9% | -22.2% | +42.7% | -2.8% | +40.3% | -12.2% | +13.6% | +0.9% | +9.1% | -5.3% | +18.5% | +3.7% | +4.6% | -0.6% | +6.5% | +10.5% | -2.1% | -5.8% | +15.6% | +3.3% | +15.5% | -6.9% | +8.6% | +5.6% | +7.8% | -14.3% | +12.3% | +1.8% | +12.3% | -15.7% | +24.5% | – | |
| – | +10.7% | +67.7% | -29.2% | +6.8% | +12.3% | +0.3% | +13.8% | +3.9% | +11.1% | +2.1% | +5.5% | +1.5% | +50.2% | +10.1% | -0.9% | +0.9% | +5.4% | +7.5% | +2.2% | +11.6% | +4.4% | +1.5% | +4.5% | +5.7% | -1.2% | +4.4% | +3.6% | -0.9% | -0.7% | +9.1% | -3.0% | +4.6% | +4.6% | -3.3% | +6.2% | +4.1% | +3.7% | -6.0% | +9.7% | – | |
| – | -9.8% | +10.1% | +5.8% | +57.2% | -32.6% | +1.3% | +8.7% | -2.1% | +32.5% | -22.5% | +11.7% | +46.7% | -13.7% | -6.6% | -6.2% | +17.2% | -5.5% | -2.3% | +208.6% | -64.9% | +40.6% | -13.1% | -0.5% | +7.5% | +7.6% | +7.0% | +20.7% | -3.8% | +56.9% | -35.9% | +525.4% | -83.8% | +14.0% | -1.9% | -0.1% | +5.5% | -5.7% | -1.2% | +3.3% | – | |
| – | +3.6% | +3.1% | +12.3% | -5.1% | +11.7% | -3.7% | +5.8% | 0.0% | +11.6% | -4.0% | +6.4% | +2.0% | +22.3% | -6.7% | +5.2% | -3.8% | +14.8% | -9.3% | +1.3% | +2.4% | +28.0% | -18.6% | -20.0% | +47.0% | +10.2% | -11.1% | +9.5% | +0.7% | +39.9% | -7.2% | +8.6% | -0.1% | +1.6% | +5.0% | +7.1% | +4.8% | +9.4% | +1.4% | +17.9% | – | |
| – | -6.0% | +8.0% | +7.7% | +38.1% | -23.3% | -0.2% | +7.8% | -1.5% | +26.4% | -17.7% | +10.1% | +33.6% | -5.6% | -6.6% | -1.4% | +9.0% | +0.1% | -4.5% | +147.4% | -56.8% | +37.2% | -14.6% | +2.1% | +10.9% | +7.4% | +34.8% | -12.8% | -2.9% | +3.2% | +4.1% | +379.0% | -78.2% | +15.8% | +21.5% | -20.9% | +4.9% | -1.0% | -0.3% | +9.7% | – | |
| – | – | +583.3% | -80.5% | -718.6% | – | +2.5% | +34.1% | +19.0% | -37.9% | +116.7% | -2.5% | -63.2% | +455.2% | +30.6% | -0.3% | -6.4% | +10.9% | +19.0% | -104.3% | – | -16.8% | +18.6% | +6.3% | +1.8% | -8.3% | -24.6% | +31.8% | +1.1% | -4.8% | +15.3% | -408.4% | – | -8.1% | -38.6% | +82.7% | +3.0% | +9.6% | -12.5% | +9.6% | – | |
| – | +1.5% | -18.0% | -12.5% | -7.4% | -7.6% | +34.6% | +7.5% | -55.1% | -41.4% | +211.5% | -0.2% | -1.9% | -2.1% | -0.8% | -1.9% | -0.1% | +17.6% | -3.7% | -1.3% | -1.4% | -1.0% | -1.3% | -2.0% | -6.2% | -15.3% | -1.7% | -1.8% | -2.7% | -2.8% | -1.9% | -4.8% | -24.2% | -62.7% | +7.1% | +23.3% | -10.8% | +0.0% | – | – | – | |
| – | – | +1,148.6% | -86.0% | -1,274.9% | – | +90.9% | +0.9% | -37.0% | -76.2% | +885.2% | +2.2% | -78.4% | +858.0% | -2.9% | +25.4% | -9.6% | +19.1% | -7.6% | -105.4% | – | -19.6% | +9.6% | +7.3% | +14.8% | -8.5% | -17.2% | +30.3% | +1.5% | -2.7% | +11.5% | -365.1% | – | -7.2% | -35.7% | +75.7% | +1.2% | +2.5% | -5.9% | +11.1% | – | |
| – | -1,581.7% | – | +8.8% | -3,003.0% | – | -223.4% | – | -22.1% | -18,630.1% | – | +15.9% | -78.0% | +612.8% | -41.5% | -122.8% | – | +262.6% | -41.0% | -166.2% | – | -56.3% | +91.2% | +11.0% | +15.0% | +4.9% | -25.7% | +28.2% | -41.5% | +24.3% | +0.4% | +12.8% | -11.7% | +25.1% | -62.4% | +197.4% | -13.7% | -35.2% | +58.3% | +31.8% | – | |
| – | – | +652.0% | -92.7% | -672.1% | – | +108.8% | -1.4% | -37.9% | +1,104.3% | -82.7% | -0.4% | -78.5% | +914.0% | +3.3% | +38.9% | -20.3% | -9.5% | +8.1% | -89.8% | +1,173.0% | -9.6% | -1.0% | +6.4% | +14.8% | -12.0% | -14.5% | +30.9% | +13.1% | -6.4% | +13.5% | -426.8% | – | -12.7% | -29.2% | +59.8% | +4.8% | +10.0% | -13.4% | +6.6% | – | |
| – | – | +407.4% | -77.2% | -696.9% | – | +71.2% | +1.1% | -33.1% | -65.8% | +545.6% | +2.1% | -70.0% | +546.0% | -2.6% | +23.9% | -9.1% | +18.8% | -7.4% | -99.7% | +43,349.7% | -18.6% | +9.3% | +7.0% | +14.0% | -8.2% | -16.4% | +28.9% | +1.5% | -1.2% | +10.3% | -347.8% | – | -7.8% | -34.0% | +71.2% | +1.3% | +2.3% | -5.7% | +6.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.